Gooseberry Extract Study Confirms Circulation Benefits

NEW BRUNSWICK, N.J..Indian gooseberry (Phyllanthus emblica) extract significantly decreased platelet aggregation, demonstrating blood circulation and heart health benefits, a new study in Phytomedicine suggests.

The randomized, open-label, crossover study analyzed the extract's effects on 10 type 2 diabetic patients (Phytomedicine. 2013 Nov 28. pii: S0944-7113(13)00433-9). Subjects received either 500mg P. emblica extract (as Capros^®  from Natreon), 75mg clopidogrel, 75mg ecosprin, 500mg P. emblicaplus75mg clopidogrel, or 500mg P. emblicaplus75mg ecosprin. The extract alone reduced platelet aggregation by more than 36 percent, compared to clopidogrel's and ecosprin's decreases, 50 and 51 percent respectively. Researchers noted P. emblica extract did not significantly affect bleeding and clotting times, whether used alone or in conjunction with the drugs, nor did it cause any adverse effects or bleeding events.

"The results illustrate how Capros^® may provide benefits for healthy blood circulation and heart health through reduced platelet aggregation," said Sanni Raju, Ph.D., R.Ph., chairman and CEO of Natreon. "The study was done in type II diabetes patients that are at a higher risk for abnormal platelet function. We're very pleased with the positive results and with growing scientific support for Capros^®, we're excited about the heart health benefits it offers to dietary supplement manufacturers seeking to introduce new products or differentiate existing brands in the category."

In the past three years, Natreon has invested more than a million dollars in clinical research. This study is one of more than 10 studies the company plans to publish in the coming year.